Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.

Loomba R, Ratziu V, Harrison SA; NASH Clinical Trial Design International Working Group. Gastroenterology. 2021 Nov 22:S0016-5085(21)03795-1. doi: 10.1053/j.gastro.2021.10.051.